Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Rosuvastatin vs Rosuvastatin in T2D with Hypertriglyceridemia
NCT04700436Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in hypertriglyceridemia, sponsored by Seoul National University Hospital. Started Jan 2020; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT04700436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700436.